YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Parnax Lab
Parnax Lab
BSE: 506128NSE: ISIN: INE383L01019

23rd-Jun-2021 20:54Source: BSE

Parnax Lab - Board Meeting Intimation for Approval Of Audited Stand-Alone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2021.

PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve Standalone and Consolidated Audited IND-AS compliant Financial Results along with Auditor Report for the quarter and year ended on 31st March, 2021 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015.

2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director.